July 28, 2017
Agios Pharmaceuticals
Agios to Webcast Conference Call of Second Quarter 2017 Financial Results on August 8, 2017
July 27, 2017
Allena Pharmaceuticals
European Commission Grants Orphan Drug Designation to Allena Pharmaceuticals' Investigational Therapy for the Treatment of Primary Hyperoxaluria
July 27, 2017
Blueprint Medicines
Blueprint Medicines to Evaluate Opportunities to Advance Rare Disease Discovery Program in Fibrodysplasia Ossificans Progressiva Following Discontinuation of Collaboration with Alexion
July 27, 2017
CytomX Therapeutics
CytomX Therapeutics to Announce Second Quarter 2017 Financial Results and Provide Mid-Year Update
July 26, 2017
Blueprint Medicines
Blueprint Medicines to Report Second Quarter 2017 Financial Results on Wednesday, August 2, 2017